94 related articles for article (PubMed ID: 2993980)
1. [IIB-type Willebrand disease (a case of increased ristomycin-induced aggregation)].
Boda Z; Hársfalvi J; Rák K
Orv Hetil; 1985 Aug; 126(32):1957-60. PubMed ID: 2993980
[No Abstract] [Full Text] [Related]
2. Factor VIII/von Willebrand factor binding to von Willebrand's disease platelets.
Gralnick HR; Williams SB; Shafer BC; Corash L
Blood; 1982 Aug; 60(2):328-32. PubMed ID: 6807372
[TBL] [Abstract][Full Text] [Related]
3. Dissociation between factor VIII (activity and antigen) and ristocetin-induced platelet aggregation in von Willebrand's disease.
Barbui T; Dini E
Acta Haematol; 1975; 53(1):44-8. PubMed ID: 807074
[TBL] [Abstract][Full Text] [Related]
4. [Studies on the effects of five monoclonal antibodies, polyclonal rabbit antibody and homologous antibody to human F VIII/vWF on ristocetin-induced platelet agglutination and platelet retention by glass bead column].
Ogata K; Minami S; Kamiya T
Rinsho Ketsueki; 1985 Jul; 26(7):1042-9. PubMed ID: 2414486
[No Abstract] [Full Text] [Related]
5. [von Willebrand's disease with an increased ristocetin-induced platelet aggregation and a qualitative abnormality of the factor VIII protein (author's transl)].
Takahashi H; Oda E; Hattori A; Kobayashi I; Takahashi K; Sakuragawa N; Shibata A
Rinsho Ketsueki; 1980 Apr; 21(4):544-54. PubMed ID: 6774131
[No Abstract] [Full Text] [Related]
6. [Ristocetin-induced platelet aggregation in von Willebrand's disease, thrombasthenia and essential athrombia with special reference to AHF-like antigen (author's transl)].
Ishiguro J; Kondo M; Ogata K; Takahashi T; Kamiya T
Rinsho Ketsueki; 1975 Jul; 16(7):716-24. PubMed ID: 1080812
[No Abstract] [Full Text] [Related]
7. [Pathophysiology of platelet anomalies and its analysis. (4). Abnormality of the platelet function in von Willebrand's disease].
Yoshioka A; Takahashi Y
Rinsho Byori; 1983 Nov; 31(11):1176-85. PubMed ID: 6423868
[No Abstract] [Full Text] [Related]
8. Agglutination of formalin-fixed, platelet-type von Willebrand's disease platelets by human von Willebrand factor.
Takahashi H; Shibata A
Thromb Haemost; 1984 Dec; 52(3):267-70. PubMed ID: 6241752
[TBL] [Abstract][Full Text] [Related]
9. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
Weiss HJ; Rogers J; Brand H
J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
[TBL] [Abstract][Full Text] [Related]
10. Acquired von Willebrand syndrome with inhibitors both to factor VIII clotting activity and ristocetin-induced platelet aggregation.
Stableforth P; Tamagnini GL; Dormandy KM
Br J Haematol; 1976 Aug; 33(4):565-73. PubMed ID: 1087568
[TBL] [Abstract][Full Text] [Related]
11. Interactions of purified rat factor VIII/von Willebrand factor with rat and human platelets--effect of albumin and ristocetin.
Dejana E; Furlan M; Barbieri B; Donati MB; Beck EA
Thromb Haemost; 1984 Aug; 52(1):57-9. PubMed ID: 6437011
[TBL] [Abstract][Full Text] [Related]
12. Mapping and functional studies of two alloantibodies developed in patients with type 3 von Willebrand disease.
Tout H; Obert B; Houllier A; Fressinaud E; Rothschild C; Meyer D; Girma JP
Thromb Haemost; 2000 Feb; 83(2):274-81. PubMed ID: 10739386
[TBL] [Abstract][Full Text] [Related]
13. Type IIB Tampa: a variant of von Willebrand disease with chronic thrombocytopenia, circulating platelet aggregates, and spontaneous platelet aggregation.
Saba HI; Saba SR; Dent J; Ruggeri ZM; Zimmerman TS
Blood; 1985 Aug; 66(2):282-6. PubMed ID: 3926021
[TBL] [Abstract][Full Text] [Related]
14. Von Willebrand disease with an increased ristocetin-induced platelet aggregation and a qualitative abnormality of the factor VIII protein.
Takahashi H; Sakuragawa N; Shibata A
Am J Hematol; 1980; 8(3):299-308. PubMed ID: 6774612
[TBL] [Abstract][Full Text] [Related]
15. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
[TBL] [Abstract][Full Text] [Related]
16. [An inhibitor in the Willebrand-Jürgens syndrome and its effect on the factor VIII molecule properties].
Lenk H; Weissbach G; Domula M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(6):826-34. PubMed ID: 85595
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity in von Willebrand's disease.
Ruggeri ZM; Zimmerman TS
Prog Clin Biol Res; 1981; 72():139-48. PubMed ID: 6801683
[No Abstract] [Full Text] [Related]
18. [Molecular biology of factor VIII in hemostasia (author's transl)].
Vicente García V; San Miguel Izquierdo J; Alberca Silva I
Med Clin (Barc); 1979 Oct; 73(7):294-301. PubMed ID: 315503
[No Abstract] [Full Text] [Related]
19. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
[TBL] [Abstract][Full Text] [Related]
20. Evidence that factor VIII and the ristocetin aggregating factor (VIIIRist) are separate molecular entities.
Hougie C; Sargeant RB; Brown JE; Baugh RF
Proc Soc Exp Biol Med; 1974 Oct; 147(1):58-61. PubMed ID: 4548194
[No Abstract] [Full Text] [Related]
[Next] [New Search]
